Inactive Instrument

Calendar Swedish Orphan Biovitrum AB Xetra

Equities

B6E

SE0000872095

Real-time Estimate Tradegate 20:40:36 16/07/2024 BST 5-day change 1st Jan Change
24.12 EUR 0.00% Intraday chart for Swedish Orphan Biovitrum AB 0.00% 0.00%

Chart calendar Swedish Orphan Biovitrum AB

6caa70a2eb502c2df0b0b.9EMqWyi6EsANyG6jmjyEriLEMf1leYVI7bbKI3hfzTk.riR-KRuLXLRAhhvr-GrG-FeKbrcwLOo-h4ObDigYnlPFLUYyWvxepEGAPw~b490e41130dedbd650439cc1aa5f1bb4

Upcoming events on Swedish Orphan Biovitrum AB

27/08/2024 Handelsbanken Life Science Innovation Day
03/09/2024 Wells Fargo Healthcare Conference
05/09/2024 Morgan Stanley Global Healthcare Conference
18/09/2024 Pareto Healthcare Conference
23/10/2024 Q3 2024 Earnings Release
04/02/2025 Q4 2024 Earnings Release
23/04/2025 Q1 2025 Earnings Release (Projected)
21/07/2025 Q2 2025 Earnings Release (Projected)
22/10/2025 Q3 2025 Earnings Release (Projected)
04/02/2026 Q4 2025 Earnings Release (Projected)

Past events on Swedish Orphan Biovitrum AB

Today Q2 2024 Earnings Release
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Poster No:6577
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Poster No:6578
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Poster No:6579
14/05/2024 14:00 Annual General Meeting
25/04/2024 15:00 Q1 2024 Earnings Call
25/04/2024 07:00 Q1 2024 Earnings Release
08/02/2024 13:00 Q4 2023 Earnings Call
08/02/2024 09:22 Q4 2023 Earnings Release
08/12/2023 American Society of Hematology Meeting
01/11/2023 American Society of Nephrology Kidney Week Meeting
30/10/2023 12:00 Q3 2023 Earnings Call
30/10/2023 07:37 Q3 2023 Earnings Release
18/09/2023 14:00 Investor Meeting - KOL
27/08/2023 Rights Issue: 1 new share @ 142 SEK for 7 existing shares
15/08/2023 09:00 Extraordinary Shareholders Meeting
19/07/2023 14:30 Investor Meeting - Key Opinion Leader
18/07/2023 12:00 Q2 2023 Earnings Call
18/07/2023 09:39 Q2 2023 Earnings Release
28/06/2023 Investor Meeting - Stiefel

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million SEK
Released
Forecast
Spread
14 248
14 210
0.26%
15 261
15 155
0.7%
15 529
15 338
1.24%
18 790
18 363
2.32%
22 123
21 968
0.71%

25 570

EBITDA
Million SEK
Released
Forecast
Spread
6 121
6 302
-2.87%
6 830
6 196
10.24%
5 740
5 466
5.01%
6 758
6 072
11.3%
7 676
7 475
2.69%

9 650

EBIT
Million SEK
Released
Forecast
Spread
4 533
4 774
-5.04%
4 818
4 110
17.24%
3 733
3 539
5.47%
4 488
4 051
10.78%
4 485
4 437
1.07%

6 010

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
4 247
4 540
-6.46%
4 217
3 562
18.38%
3 295
3 108
6.03%
3 321
3 270
1.56%
2 954
3 399
-13.09%

4 286

Net income
Million SEK
Released
Forecast
Spread
3 304
3 556
-7.08%
3 245
2 743
18.31%
2 679
2 375
12.8%
2 638
2 620
0.69%
2 409
2 695
-10.6%

3 432

EPS
SEK
Released
Forecast
Spread
11,2
12,1
-6.99%
10,9
9,25
17.9%
9,03
8,01
12.75%
8,84
8,84
0.01%
7,39
8,46
-12.69%

10,3

Announcement Date13/02/2018/02/2110/02/2208/02/2308/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million SEK
Released
Forecast
Spread
4 925
4 470
10.17%
3 876
3 533
9.72%
3 999
3 905
2.41%
5 991
5 512
8.7%
5 239
5 142
1.89%
4 872
4 403
10.66%
5 168
4 628
11.66%
6 844
6 735
1.62%
6 256
5 805
7.77%
5 442
5 125
6.18%

6 112


7 323


6 538


6 034

EBITDA
Million SEK
Released
Forecast
Spread
1 461
1 608
-9.17%
997
854
16.69%
1 278
1 170
9.27%
2 493
2 298
8.49%
2 159
1 768
22.11%
1 286
1 079
19.18%
1 585
1 122
41.3%
2 645
2 681
-1.34%
2 377
2 015
17.97%
1 556
1 390
11.91%

2 041


3 195


2 704


2 448

EBIT
Million SEK
Released
Forecast
Spread
1 437
1 169
22.96%
423
376
12.36%
699
739
-5.42%
1 916
1 764
8.6%
1 495
1 208
23.75%
413
531
-22.27%
547
441
23.98%
1 691
1 970
-14.16%
1 468
1 114
31.78%
612
516
18.54%

1 452


2 169


1 765


1 509

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
674
1 061
-36.48%
317
278
13.96%
564
495
13.99%
1 766
1 689
4.57%
1 325
1 032
28.33%
275
329
-16.51%
116
239
-51.51%
1 237
1 804
-31.41%
982
811
21.04%
275
233
18.01%

929


2 045


1 581


1 355

Net income
Million SEK
Released
Forecast
Spread
543
909
-40.23%
258
211
22.49%
451
418
8.01%
1 386
1 303
6.36%
1 067
825
29.36%
222
244
-9.04%
94,0
192
-50.92%
1 026
1 308
-21.53%
800
644
24.19%
224
180
24.47%

734


1 565


1 249


1 071

EPS
SEK
Released
Forecast
Spread
1,83
3,28
-44.21%
0,86
0,73
17.21%
1,51
1,36
10.96%
4,64
4,41
5.19%
3,56
2,79
27.8%
0,74
1,07
-30.52%
0,30
0,45
-33.96%
2,99
3,98
-24.86%
2,33
1,76
32.33%
0,65
0,58
11.42%

1,98


5,46


3,53


3,03

Announcement Date28/04/2219/07/2227/10/2208/02/2327/04/2318/07/2330/10/2308/02/2425/04/2416/07/24----
  1. Stock Market
  2. Equities
  3. SOBI Stock
  4. B6E Stock
  5. Calendar Swedish Orphan Biovitrum AB